Becton Dickinson develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products for health-care institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry and the public worldwide.
Stock Market Value: ~$66.65B ($229.85 per share)
Becton Dickinson shares in the past 12 months
shared its intent to separate its biosciences and diagnostics solutions business.
considering the divesture of its Life Sciences segment. Whether this is because the company has been considering this anyway or because it heard Starboard loud and clear is irrelevant. Starboard is the type of activist that does not care who gets the credit, as long as the best decisions are made for shareholders.
Ken Squire is the founder and president of 13D Monitor, an institutional research service on shareholder activism, and the founder and portfolio manager of the 13D Activist Fund, a mutual fund that invests in a portfolio of activist 13D investments.
